-
Recognising Future Talent: Combilift Gives Future Engineers a Lift - 1 day ago
-
Autopack Group launches new division Autoweigh at PPMA Show with smallest ever multihead weigher - September 30, 2026
-
BRIGADE ELECTRONICS LAUNCHES HALONIQ VIDEO TELEMATICS ECOSYSTEM - September 30, 2026
-
58% of retailers are ready to give AI control but 37% of consumers demand the final say - September 30, 2026
-
When the highest safety requirements demand purpose-built vehicle solutions - September 30, 2026
-
Dodge AI raises $2.65M from Accel and Google to fix the $600B enterprise firefighting problem - September 29, 2026
-
BCMPA Connects Ambitious Brands with Outsourcing Experts at White &Private Label Expo 2026 - September 29, 2026
-
goplasticpallets.com hits 3,000 tonne recycling milestone to save CO2 equivalent of 640 cars - September 29, 2026
-
Keep your cool with a Flexi - September 25, 2026
-
GREENORE PORT ADOPTS VIDEO TELEMATICS TO SUPPORT HEALTH AND SAFETY COMMITMENT - September 23, 2026
86% of pharma and biotech companies plan to invest in ‘digitally agile’ supply chains in the next 12 months
Investment in digital agility to improve operational resilience is the area where most work is needed
86% of pharma and biotech companies say they plan to become more digitally agile, according to a new survey of 100 senior pharmaceutical executives.
The survey, conducted by LogiPharma – the world’s leading annual conference covering pharmaceutical and medical device supply chains – asked global heads and directors of supply chain, logistics, procurement and IT how their organisations were upgrading their existing supply chain network to become more digitally agile.
Allowing logistics networks to be flexible and adapt to rapid changes and new innovations, including responding flexibly to geopolitical events and incorporating AI into networks were examples of how pharmaceutical and biotech companies say they will be enhancing their supply chains over the next year.
The number one challenge in building a digital supply chain was gaining visibility on the data and digital maturity roadmap, ensuring organisations can understand how digital transformation can help them recognise and plan for future challenges.
“One of the biggest focuses for our organisation has been utilising supply chain mapping solutions and embedding AI into that solution,” says Peter Stolba, Vice President, Business
Operations and Supply Chain, Trilink Biotechnologies.
“We have recently partnered with an external provider that has effectively mapped our tier one through to tier three suppliers. They have then overlaid AI to manage any risks that take place.
“Should any delays occur at a port, or airport, we are seeing real-time alerts and can respond sooner. Getting supplies has been incredibly difficult over the past two years and knowing immediately how to react to disruptions in the market has been essential.”
Learning from the pandemic
The global pandemic and geopolitical events such as the war in Ukraine have reinforced the need for operational resilience, particularly across global supply chains for vital products like pharmaceuticals.
Those surveyed said most work was needed in data management (22%), to improve the operational resilience, followed by temperature controls (21%) and investing in digital agility (18%).
61% felt that the most important factor for strengthening future supply chains was closer relationships with their suppliers to improve end-to-end visibility.
Peter Stolba adds:
“I think the pandemic has fueled the need for data visibility and the justification for investment into building a more robust digital supply chain. It is important that we leverage the information we have, and make key decisions based on our data points.”












